These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36384160)

  • 1. FasL is a catabolic factor in alveolar bone homeostasis.
    Apaza Alccayhuaman KA; Heimel P; Lee JS; Tangl S; Kuchler U; Marchesan J; Panahipour L; Lettner S; Matalová E; Gruber R
    J Clin Periodontol; 2023 Mar; 50(3):396-405. PubMed ID: 36384160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth-dependent phenotype in FasL-deficient mandibular/alveolar bone.
    Svandova E; Sadoine J; Vesela B; Djoudi A; Lesot H; Poliard A; Matalova E
    J Anat; 2019 Aug; 235(2):256-261. PubMed ID: 31148178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preimplantation maternal stress impairs embryo development by inducing oviductal apoptosis with activation of the Fas system.
    Zheng LL; Tan XW; Cui XZ; Yuan HJ; Li H; Jiao GZ; Ji CL; Tan JH
    Mol Hum Reprod; 2016 Nov; 22(11):778-790. PubMed ID: 27475493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of functional Fas ligand enhances intestinal tumorigenesis in the Min mouse model.
    Fingleton B; Carter KJ; Matrisian LM
    Cancer Res; 2007 May; 67(10):4800-6. PubMed ID: 17510409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FasL Is Required for Osseous Healing in Extraction Sockets in Mice.
    Apaza Alccayhuaman KA; Heimel P; Lee JS; Tangl S; Strauss FJ; Stähli A; Matalová E; Gruber R
    Front Immunol; 2021; 12():678873. PubMed ID: 34135904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis with FasL+ cell infiltration in the periphery and thymus of corrected autoimmune mice.
    Kobata T; Takasaki K; Asahara H; Hong NM; Masuko-Hongo K; Kato T; Hirose S; Shirai T; Kayagaki N; Yagita H; Okumura K; Nishioka K
    Immunology; 1997 Oct; 92(2):206-13. PubMed ID: 9415028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas ligand (gld)- and Fas (lpr)-deficient mice do not show alterations in the extravasation or apoptosis of inflammatory neutrophils.
    Fecho K; Cohen PL
    J Leukoc Biol; 1998 Sep; 64(3):373-83. PubMed ID: 9738665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential role for hematopoietic Fas ligand (FasL) in the suppression of melanoma lung metastasis revealed in bone marrow chimeric mice.
    Hall CL; Yao M; Hill LL; Owen-Schaub LB
    Clin Exp Metastasis; 2004; 21(3):251-6. PubMed ID: 15387375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of endogenous Fas (CD95/Apo-1) ligand in balloon-induced apoptosis, inflammation, and neointima formation.
    Matter CM; Chadjichristos CE; Meier P; von Lukowicz T; Lohmann C; Schuler PK; Zhang D; Odermatt B; Hofmann E; Brunner T; Kwak BR; Lüscher TF
    Circulation; 2006 Apr; 113(15):1879-87. PubMed ID: 16606788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal tubular epithelial cell apoptosis by Fas-FasL-dependent self-injury can augment renal allograft injury.
    Du C; Guan Q; Yin Z; Masterson M; Zhong R; Jevnikar AM
    Transplant Proc; 2003 Nov; 35(7):2481-2. PubMed ID: 14611992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fas-mediated cytotoxicity is not required for rejection of murine nonvascularized heterotopic cardiac allografts.
    Djamali A; Odorico JS
    Transplantation; 1998 Dec; 66(12):1793-801. PubMed ID: 9884278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice deficient in fas ligand (gld) or fas (lpr) show few alterations in granulopoiesis.
    Fecho K; Bentley SA; Cohen PL
    Cell Immunol; 1998 Aug; 188(1):19-32. PubMed ID: 9743554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloantigen-driven T cell death mediated by Fas ligand and tumor necrosis factor-alpha is not essential for the induction of allograft acceptance.
    Wagener ME; Konieczny BT; Dai Z; Ring GH; Lakkis FG
    Transplantation; 2000 Jun; 69(11):2428-32. PubMed ID: 10868653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas and Fas ligand expressed on cells of the immune system, not on the target tissue, control induction of experimental autoimmune uveitis.
    Wahlsten JL; Gitchell HL; Chan CC; Wiggert B; Caspi RR
    J Immunol; 2000 Nov; 165(10):5480-6. PubMed ID: 11067900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mice Lacking PLAP-1/Asporin Show Alteration of Periodontal Ligament Structures and Acceleration of Bone Loss in Periodontitis.
    Kinoshita M; Yamada S; Sasaki J; Suzuki S; Kajikawa T; Iwayama T; Fujihara C; Imazato S; Murakami S
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periodontal inflammation triggers a site-specific and wide radius of calcium metabolic effects on alveolar bone.
    Kuraji R; Wu YH; Hashimoto S; Miyashita Y; Mishiro S; Ito H; Kamarajan P; Kapila Y; Numabe Y
    J Periodontal Res; 2021 Apr; 56(2):314-329. PubMed ID: 33314132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of lymphoid hyperplasia and hypergammaglobulinemia in lupus-prone mice (gld) by Fas-ligand gene transfer.
    Hong NM; Masuko-Hongo K; Sasakawa H; Kato T; Shirai T; Okumura K; Nishioka K; Kobata T
    J Autoimmun; 1998 Aug; 11(4):301-7. PubMed ID: 9776707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of chronic sialadenitis in a murine model of Sjögren's syndrome by local fasL gene transfer.
    Fleck M; Zhang HG; Kern ER; Hsu HC; Müller-Ladner U; Mountz JD
    Arthritis Rheum; 2001 Apr; 44(4):964-73. PubMed ID: 11315936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted mutation of Fas ligand gene attenuates brain inflammation in experimental stroke.
    Niu FN; Zhang X; Hu XM; Chen J; Chang LL; Li JW; Liu Z; Cao W; Xu Y
    Brain Behav Immun; 2012 Jan; 26(1):61-71. PubMed ID: 21802508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster.
    Lynch DH; Watson ML; Alderson MR; Baum PR; Miller RE; Tough T; Gibson M; Davis-Smith T; Smith CA; Hunter K
    Immunity; 1994 May; 1(2):131-6. PubMed ID: 7889405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.